Pacific Biosciences Of California (PACB) Market Capitalization (2010 - 2026)

Pacific Biosciences Of California has reported Market Capitalization for 17 years, with the latest figure at $522.2 million in Q2 2026.

• On a quarterly basis, Market Capitalization rose 40.2% year-over-year to $522.2 million in Q2 2026; TTM through Jun 2026 was $522.2 million, a 40.2% increase from a year earlier, with the FY2025 full-year figure at $564.7 million, up 4.8% from the prior year.
• Market Capitalization was $522.2 million for Q2 2026 at Pacific Biosciences Of California, up from $409.8 million in the prior quarter.
• The five-year high for Market Capitalization was $3.3 billion in Q2 2023, with the low at $354.0 million in Q1 2025.
• Average Market Capitalization over 5 years is $1.2 billion, with a median of $779.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Market Capitalization surged 235.34% in 2023, then plunged 88.79% in 2024.
• Over 5 years, Market Capitalization stood at $1.9 billion in 2022, then surged by 41.76% to $2.6 billion in 2023, then sank by 79.49% to $538.8 million in 2024, then climbed by 4.8% to $564.7 million in 2025, then retreated by 7.53% to $522.2 million in 2026.
• The last three Market Capitalization figures came in at $522.2 million (Q2 2026), $409.8 million (Q1 2026), and $564.7 million (Q4 2025), per Business Quant data.